Abstract:
The endothelium plays a central role in the regulation of vascular wall cellularity and tone by secreting an array of mediators of importance in intercellular communication. Nutrient deprivation of human endothelial cells (EC) evokes unconventional forms of secretion leading to the release of nanovesicles distinct from apoptotic bodies and bearing markers of multivesicular bodies (MVB). Nutrient deficiency is also a potent inducer of autophagy and vesicular transport pathways can be assisted by autophagy. Nutrient deficiency induced a significant and rapid increase in autophagic features, as imaged by electron microscopy and immunoblotting analysis of LC3-II/LC3-I ratios. Increased autophagic flux was confirmed by exposing serum-starved cells to bafilomycin A1. Induction of autophagy was followed by indices of an apoptotic response, as assessed by microscopy and poly (ADP-ribose) polymerase cleavage in absence of cell membrane permeabilization indicative of necrosis. Pan-caspase inhibition with ZVAD-FMK did not prevent the development of autophagy but negatively impacted autophagic vacuole (AV) maturation. Adopting a multidimensional proteomics approach with validation by immunoblotting, we determined that nutrient-deprived EC released AV components (LC3I, LC3-II, ATG16L1 and LAMP2) whereas pan-caspase inhibition with ZVAD-FMK blocked AV release. Similarly, nutrient deprivation in aortic murine EC isolated from CASP3/caspase 3-deficient mice induced an autophagic response in absence of apoptosis and failed to prompt LC3 release. Collectively, the present results demonstrate the release of autophagic components by nutrient-deprived apoptotic human cells in absence of cell membrane permeabilization. These results also identify caspase-3 as a novel regulator of AV release.
Received: July 24, 2011; Accepted: February 20, 2012; Published Online: June 1, 2012
The endothelium plays a central role in the regulation of vascular wall cellularity and tone by secreting an array of mediators of importance in intercellular communication. Endothelial apoptosis in response to various cellular stresses either immune or nonimmune is critical to most vascular diseases. Apoptotic cells actively release membrane-bound apoptotic bodies originating from blebbing of the cell membrane.
During autophagy, autophagosome formation begins with the isolation of autophagic cargo through membrane-wrapping of cytoplasmic components or organelles targeted for lysosomal degradation. Endoplasmic reticulum as well as plasma membranes participate in the initiation of autophagosome formation.
In the present work, we evaluated whether human cells can also release AV and whether caspase activation regulates this pathway. Several cues prompted us to evaluate the importance of caspases in extracellular export of AV components in eukaryotes. Caspase activation and more specifically activation of the effector caspase-3 has been implicated in the orchestration of a finely regulated paracrine response leading to the release of protein and lipid mediators of importance in tissue remodeling at sites of cell deletion.
We showed previously that nutrient deprivation associated with serum starvation (SS) sequentially activates CASP9/caspase 9 in human EC, leading to caspase-dependent apoptotic cell death.
Figure 1. Serum starvation (SS) in EC induces both apoptotic and autophagic features. (A and B) Electron micrographs of normal and apoptotic EC. The nucleus (Nu) of EC exposed to complete growth medium (Normal) displays an elongated aspect whereas that of serum-starved EC (SS) for 4 h appears rounded and condensed, characteristic of apoptosis. Scale bar: 1 µm. (C) Percentages of cells with increased chromatin condensation (apoptosis) and cell membrane permeabilization (necrosis), as evaluated by HO and PI staining, in EC exposed to normal medium (N) or SS for 1–4 h. *p ≤ 0.0007 vs. N, n = 6. (D) Immunoblot for uncleaved and cleaved forms of PARP in EC treated as in (C), representative of 4 experiments. (E) Upper panel: Time-course of LC3 turnover, by immunoblot, in EC treated as in (A–D). Lower panel: Densitometry analysis of LC3-II/LC3-I ratios in EC exposed to N or SS for 1–4 h. *p ≤ 0.01 vs. N. Representative of four experiments. (F) LC3-I and -II immunoblot in EC exposed to N, SS and SS + bafilomycin A1 5 nM for 4 h (the immunoblot corresponds to two parts of the same gel). Representative of four experiments. (G–K) Morphological characterization of AV in EC serum starved for 4 h. (G) AV with intact cytoplasmic portions or organelles delimited by multiple membranes with internal electron-lucent material and cytoplasm. (H and I) AV with various stages of degraded cytoplasmic material, characterized by increased electron density within vacuoles surrounded by single or double delimiting membranes. (J) AV displaying a more advanced degradation stage with multilamelar lysosomal bodies (white star). (K) Amphisomes are characterized by the presence of both autophagosomal electron-dense material with a delimiting membrane and MVB nanovesicular content. Scale bar: 0.5 µm. (L) Total cytoplasmic area (µm2) occupied by AV per cell profile in EC exposed for 4 h to N and SS, respectively. Area of AV per cell profile (n = 20) was assessed in relation to the cell cytoplasm (nuclei were not included in the evaluation); *p ≤ 0.001 vs. N.
We then examined the kinetics of autophagy in this system. LC3-II/LC3-I ratios increased significantly in EC serum starved for 2 h. This heightened ratio persisted for the entire study duration (
To functionally address the interplay between caspase activation and autophagy during serum starvation, EC were exposed to SS in the presence of the pan-caspase inhibitor ZVAD-FMK. Caspase inhibition blocked the nuclear changes associated with apoptosis development, as evaluated by fluorescence microscopy as well as PARP cleavage (
Figure 2. Caspase inhibition does not prevent development of autophagy in serum-starved EC. (A) Percentages of cells with increased chromatin condensation (apoptosis) and cell membrane permeabilization (necrosis), as evaluated by HO and PI staining, in EC exposed to SS in presence of the pan-caspase inhibitor ZVAD-FMK (SS+ZVAD) 50 µM or SS + vehicle DMSO (SS) for 1–4 h. *p ≤ 0.002 vs. Z, n = 6. (B) Immunoblot for uncleaved and cleaved PARP in EC treated as described above. Representative of 4 experiments. (C and D) Electron micrographs of EC serum starved for 4 h with vehicle DMSO [SS, (C)] or with ZVAD-FMK 50 µM [SS+ZVAD, (D)]. Scale bar: 1 µm. (E) Mean cytoplasmic area of the cell profiles. (F) Percentage of total cytoplasmic area (µm2) occupied by AV per cell profile in EC treated as in (A–D). *p = 0.01 vs. SS; n = 30 cell profiles. (G) Mean number of AV profiles per cell profile in EC serum starved for 4 h in presence of the pan-caspase inhibitor ZVAD-FMK 50 µM (SS+ZVAD) or vehicle DMSO (SS). *p ≤ 0.0005 and **p ≤ 0.005 vs. SS; n = 30 cell profiles. (H) Time course of LC3 turnover by immunoblot in EC treated as in A (the immunoblot corresponds to two parts of the same gel). Representative of three experiments. (I–K) Native LC3 immunostaining evaluated by confocal microscopy in EC exposed either to (I) normal medium (N) or serum-starved and treated with (J) vehicle DMSO (SS) or (K) ZVAD-FMK 50 µM (SS+ZVAD). (L) Mean number of LC3 puncta per cell profile evaluated by confocal microscopy immunostaining in EC treated as above. LC3 puncta were counted in approximatly 50 cells/representative section of the sample in three different trials; p ≤ 0.0001. (M) Upper panel: LC3-I and -II immunoblot in EC exposed to vehicule (SS), SS+ZVAD (50 µM), SS + bafilomycin A1 (5 nM) or SS + ZVAD + bafilomycin A1 for 4 h. Lower panel: Densitometry analysis of the LC3-II/LC3-I ratio. *p ≤ 0.02 vs. SS, **p ≤ 0.0002 vs SS+ZVAD. Representative of four experiments.
Ultrastructural analysis of serum-starved EC by electron microscopy showed accumulation of AV at different maturation stages in proximity with the cell membrane in serum-starved EC (
Figure 3. Caspase activation regulates the formation of autophagic network. (A–E) Electron micrographs of serum-starved EC exposed to ZVAD-FMK 50 µM (SS+ZVAD) or vehicle (SS) for 4 h. (A and B) Autophagic network (islet in A) with different maturation stages observed in serum-staved EC. Multilamellar electron-dense lysosomal bodies are also represented (white stars). White arrowheads indicate contact sites between AV. Scale bars: (A) 0.5 µm; (B) 2 µm. (C–E) Electron micrographs of EC serum starved with ZVAD-FMK 50 µM (SS+ZVAD) showing individual AV (islet in D and E) as opposed to large autophagic network seen in (B). Scale bars: (C) 0.5 µm; (D and E) 2 µm. (F) Mean number of contact sites per AV profile quantified for each condition; n = 30 cell profiles per condition; p = 0.005.
Since AV accumulate in serum-starved EC upon caspase inhibition (
The following criteria were used to assess the release of AV components by apoptotic and non-apoptotic, serum-starved EC: (1) protein previously reported to be associated with AV formation, expansion or fusion; (2) protein identified in SSC or in SSC-ZVAD only or with a significant differential abundance ratio of SSC /SSC-ZVAD greater than 2.0; and (3) protein of human origin (
| No. | Protein identified by LC-MS-MS | Gene name | Function during autophagy |
| Predominant in SSC | |||
| 1 | LC3/Microtubule-associated proteins 1A/1B, light chain 3 | MAP1LC3B | Autophagosome formation and expansion. Cytosolic and membrane-bound to autophagosomes. |
| 2 | Cysteine protease ATG4D | ATG4D | Autophagosome formation and expansion. Cleaves the C-terminal part of MAP1LC3. |
| 3 | Autophagy related protein 16-like 1 | ATG16L1 | Autophagosome formation and expansion. Associates with ATG12–ATG15 complex. |
| 4 | VPS4 AAA ATPase/vacuolar protein sorting-associated protein 4B | VPS4/SKD1 | Autophagosome formation and MVB biogenesis. Fusion of autophagosomes with endosomes and lysosomes. |
| 5 | Vacuolar protein sorting-associated protein 16 homolog | VPS16 | Formation and fusion of autolysosomes and endolysosomes. |
| 6 | Lysosome-associated membrane glycoprotein 2 | LAMP2 | Fusion of autophagosomes with lysosomes. |
| Predominant in SSC-ZVAD | |||
| 1 | Ras-related protein RAB7a | RAB7A | Fusion of autophagosomes and amphisomes with lysosomes. |
Figure 4. Caspase-dependent release of AV components during serum starvation (A) Immunoblot analysis for LAMP2, LC3-I, LC3-II and ATG16L1 in 25 ml of media conditioned by EC serum staved with vehicle DMSO (SSC) or with ZVAD-FMK 50 µM (SSC ZVAD); n = 3 for ATG16L1, LC3I and LC3-II; n = 2 for LAMP2. (B–E) Electron micrographs of EC serum starved with vehicle for 4 h showing AV near and/or interacting with the cell membrane. Scale bar: (B and C) 0.5 µm; (D) 1 µm. (E) Islet of the autophagic network in (D) located near the cell membrane; contact sites (white arrowheads). Scale bar: 0.5 μm. (F) AV in EC serum starved incubated with ZVAD-FMK 50 µM (SS + ZVAD) are located farther away from the cell membrane as opposed to AV seen in EC serum starved with vehicle (SS) (D and E). Scale bar: 1 µm. (G) Islet of the AV in (F). Scale bar: 0.5 µm. (H) Distance (µm) of AV from the cell membrane in serum-starved EC treated as in (A–G). Each AV distance was measured perpendicularly to the cell membrane in electron micrographs using ImageJ software; n = 30 cell profiles for each condition *p < 0.001 vs. SS.
CASP1/caspase 1 has been identified as a molecular regulator of unconventional secretion pathways and can be inhibited by ZVAD-FMK.
Figure 5. Caspase-3-dependent release of AV components in serum-starved murine EC. (A) Percentages of cells with chromatin condensation and cell membrane permeabilization (as evaluated by HO and PI staining) in aortic EC isolated from controls (WT) and CASP3-deficient (C3−/−) mice exposed to normal medium 4 h or SS for 2–4 h. *p ≤ 0.02 vs. WT, n = 6. (B) Upper panel: Immunoblot for LC3-I/-II in EC treated as described above. Lower panel: densitometry analysis of LC3-II/LC3-I ratios for WT and C3−/− murine EC serum starved for 4 h. Representative of 16 independent WT mice and 6 C3−/− mice. (C–E) Electron micrographs of control murine EC (WT) exposed to SS for 4 h showing AV near and/or interacting with the cell membrane [islet in (E)]. Scale bars: (C and D) 2 µm; (E): 0.5 µm. (F–H) Electron micrographs of murine C3−/− EC exposed to SS for 4 h showing enhanced autophagic vacuolization located away from the cell membrane (islet in H) as compared with WT (E). Scale bars: (F and G) 2 µm; (H) 0.5 µm. (I) Upper panel: Immunoblot analysis for LC3-I and LC3-II in 10 ml of serum-free media conditioned by controls (SSC WT) or CASP3-deficient (SSC C3−/−) murine EC. Lower panel: Densitometry analysis of LC3-I and LC3-II; n = 3.
Autophagy is classically considered a degradative process responsible for the elimination of unnecessary or defective cellular proteins and organelles. In conditions of reduced nutrient availability, autophagy allows reuse of intracellular proteins to maintain energy levels and prevents the activation of programmed death pathways. Mounting evidence suggests that the autophagic system is central for the elimination of microorganisms, tumor suppression and antigen presentation.
The present work lends further support to these recent reports and demonstrates that autophagic components are released by human EC under conditions of reduced nutrient availability in association with caspase-3 activation. We determined that serum starvation rapidly increases autophagic flux in EC. We observed that autophagy predated development of apoptosis and persisted while apoptosis was activated. Necrosis however was not activated in this system, as the percentage of cells with evidence of cell membrane permeabilization did not increase during serum starvation. Unbiased proteomic analysis and validation by western blotting confirmed the presence of several autophagic proteins in medium conditioned by serum-starved EC, including LC3 and ATG16L1.
We identified caspases, and more precisely caspase-3, as novel regulators of AV maturation and release. Proteomic analysis and validation by western blotting showed that pan-caspase inhibition prevents the release of AV components in the extracellular milieu. Also, the mean distance between AV and the cell membrane increased in presence of the pan-caspase inhibitor ZVAD-FMK. Evaluation of AV maturation and release in CASP3-deficient mice corroborated these results. Serum-starved CASP3-deficient (C3−/−) EC failed to develop apoptotic nuclear features upon serum starvation but activated an autophagic response. However, extracellular release of LC3 was largely inhibited in C3−/− serum-starved EC.
Mounting evidence suggests that caspase activity regulates unconventional modes of secretion. A significant proportion of the caspase-dependent secretome of nutrient-deprived EC is composed of proteins devoid of secretion signals, indicating an association between caspase activation and unconventional secretion pathways.
The functional importance of AV release downstream of caspase activation could vary, depending on cell type and the local microenvironment. It is likely that externalization of large AV contributes to the reduction of cell volume associated with caspase-dependent apoptotic cell death.
Human umbilical vascular endothelial cells (HUVEC, Cell applications 200p-05n) were grown in endothelial cell basal medium (Lonza, CC-3121) and used at passages 2 to 4. For time course studies, HUVEC were exposed to either normal medium (N), serum-free medium (SS, RPMI, Gibco, 11875-093) SS + ZVAD-FMK (50 µM) (R&D Systems, FMK-001) for 1 to 4h or SS + vehicle (DMSO, Sigma Aldrich, D2650). Protein extracts were separated on 12% SDS-PAGE, as previously described,
Fluorescence microscopy of unfixed/unpermeabilized, adherent cells, stained with Hoechst 33342 (2′-(4-ethoxyphenyl)-5-(4-methyl-1-piperazinyl)-2.5′-bi-1H-benzimidazole) (HO, Sigma Aldrich, B2261) and propidium iodide (PI, Invitrogen, P3566), was undertaken as previously described.
HUVEC were fixed with 1% glutaraldehyde, post-fixed with 1% osmium tetroxide and embedded in Epon according to routine techniques. The tissue sections were stained with uranyl acetate and lead citrate.
Endothelial cells were cultivated in labtek (Thermo Fisher Scientific, 154534) as described above. Briefly, when reaching confluence, cells were treated during 4 h. Cells were then fixed 20 min on ice in 2% paraformaldehyde and permeabilized (0.1% Triton X-100 (Sigma, T9284) in PBS) 10 min. Prior to the overnight incubation in 1:30 LC3B antibody (Cell Signaling, 2775S), slides were blocked 1 h (Blocking solution: 2% goat serum (Sigma Aldrich, G9023), 1% BSA (Sigma Aldrich, A9647), 0.1% Tween20 in PBS (Sigma Aldrich, P1372). Secondary antibody goat anti-rabbit Alexa488 (Invitrogen, A11008) was used. Nuclear counterstain was visualized with DAPI (4′,6-diamidino-2-phenylindole, 0.05 µg/ml, (Invitrogen, D3571). The autophagic vacuoles were visualized using a Olympus multiphoton FV-1000 MER microscope with Argon laser 488 nm line and diode laser 405 nm line. The images were taken with a UPlanSApo 60X/1.35W objective lens.
Alexa 488 and DAPI were imaged with Olympus FV10-MSASW software under a Olympus Laser Confocal Scanning Microscope. For Alexa 488, the 488 nm line of the Argon laser was used for excitation and emission was detected at 520 nm. DAPI imaging was visualized using a diode laser 405 nm line and emission was detected at 461 nm. Differential interference contrast (DIC) images were captured using the transmission light detector of the confocal microscope. For semiquantitative measurement of fluorescence intensities, laser, pinhole and gain settings of the confocal microscope were kept identical among treatments. LC3 puncta were counted in approximatly 50 cells/representative section of the sample in three different trials using Photoshop CS4 (Adobe System).
Serum-free media, conditioned by apoptotic or caspase-inhibited EC, were obtained as described previously.
The protocol was approved by the Comité Institutionnel de Protection des Animaux (CIPA) of the Centre Hospitalier de l’Université de Montréal (CHUM). Male and female mice, aged 6 to 8 weeks, were derived from breeding pairs of heterozygous CASP3-deficient (B6.129S1-C3tm1Flv/J) mice obtained from Jackson Laboratory (Bar Harbor, Me). Two groups of mice were studied: homozygous CASP3-deficient (C3−/−) mice and wild-type (WT) as controls. Mice were maintained in 12 h light-dark cycle and fed ad libitum. No difference was observed between male and female mice for the different parameters investigated. The genotyping of each mouse was assessed by PCR of DNA isolated from tail biopsy samples, as described on the Jackson Laboratory website.
Endothelial cells from the thoracic aorta were isolated by an explant technique. The thoracic aorta was gently cleaned of periadventitial fat and connective tissue and was opened longitudinally and cut into 2 mm-long segments. The aortic segments of each mouse were placed on Matrigel (Basement membrane, BD Biosciences, 354234) in a 6-well plate (2 aorta/well) and incubated in DMEM low glucose (Invitrogen,11885-092) supplemented with 10% FBS (Gibco,16000-044), 10% newborn calf serum (Gibco, 16010-159), 1% penicillin-streptomycin (Invitrogen, 151-40), 12.6 U/ml heparin (LeoPharma, 35HEIJ205), 50 µg/ml endothelial cell growth supplements (VWR, CACB356006) and 100 U/mL fungizone (Invitrogen, 15290-018) at 37°C in a 95% air/5% CO2 incubator. The vessel segments were removed 4–5 d after the isolation and cells were detached with 50 U/ml dispase (BD Bioscience, CACB354235) and then plated onto 0.5% gelatin-coated 25-cm2 flasks after a week in the Matrigel. The subsequent passages up to P2 were performed with 0.25% trypsin-EDTA (Invitrogen, 25300), and cells were split in a 1:4 ratio. Endothelial cells were characterized with a CD31 (Santa Cruz Biotechnology, SC1506) and VE-Cadherin (Santa Cruz Biotechnology, SC28644) immunostaining dye for each passage.
The data, expressed as mean ± standard error of the mean, were analyzed by Student's t-test (with Bonferroni correction when appropriate) or ANOVA.
No potential conflicts of interest were disclosed.
Supplemental materials may be found here: www.landesbioscience.com/journals/autophagy/article/19768
This work was supported by research grants from the Canadian Institutes of Health Research to M.J.H. and M.B. (MOP-89869). M.J.H. is the holder of the Shire Chair in Nephrology, Transplantation and Renal Regeneration of the University of Montreal. I.S. is the recipient of a training fellowship from the Canadian Institutes of Health Research. We thank the J.-L. Lévesque Foundation for renewed support.
|
Jump to Section
|